SBC Medical Group (SBC) Competitors $4.09 -0.15 (-3.54%) Closing price 04:00 PM EasternExtended Trading$4.01 -0.08 (-1.83%) As of 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SBC vs. CELC, ARDT, LFST, PACS, NHC, VRDN, AVAH, AHCO, TDOC, and GRALShould you be buying SBC Medical Group stock or one of its competitors? The main competitors of SBC Medical Group include Celcuity (CELC), Ardent Health (ARDT), LifeStance Health Group (LFST), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Teladoc Health (TDOC), and GRAIL (GRAL). These companies are all part of the "healthcare" industry. SBC Medical Group vs. Its Competitors Celcuity Ardent Health LifeStance Health Group PACS Group National HealthCare Viridian Therapeutics Aveanna Healthcare AdaptHealth Teladoc Health GRAIL SBC Medical Group (NASDAQ:SBC) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Is SBC or CELC more profitable? SBC Medical Group has a net margin of 17.71% compared to Celcuity's net margin of 0.00%. SBC Medical Group's return on equity of 20.76% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets SBC Medical Group17.71% 20.76% 15.56% Celcuity N/A -150.07%-64.67% Do analysts rate SBC or CELC? Celcuity has a consensus target price of $50.60, suggesting a potential upside of 2.80%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than SBC Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SBC Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of SBC or CELC? 60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 89.5% of SBC Medical Group shares are held by insiders. Comparatively, 15.8% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer SBC or CELC? In the previous week, Celcuity had 8 more articles in the media than SBC Medical Group. MarketBeat recorded 19 mentions for Celcuity and 11 mentions for SBC Medical Group. Celcuity's average media sentiment score of -0.01 beat SBC Medical Group's score of -0.37 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 2 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings & valuation, SBC or CELC? SBC Medical Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSBC Medical Group$205.42M2.06$46.61M$0.3212.78CelcuityN/AN/A-$111.78M-$3.45-14.27 Which has more risk and volatility, SBC or CELC? SBC Medical Group has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. SummarySBC Medical Group beats Celcuity on 9 of the 15 factors compared between the two stocks. Get SBC Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBC vs. The Competition Export to ExcelMetricSBC Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$439.31M$7.66B$5.73B$9.80BDividend YieldN/A2.76%4.54%4.08%P/E Ratio12.7874.7930.7425.12Price / Sales2.0631.42441.58109.31Price / Cash6.9923.8337.3459.16Price / Book1.7316.418.886.24Net Income$46.61M$243.33M$3.26B$265.56M7 Day Performance-9.91%1.53%1.73%0.90%1 Month Performance-27.61%2.00%3.54%1.88%1 Year PerformanceN/A16.99%28.63%20.09% SBC Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBCSBC Medical GroupN/A$4.09-3.5%N/AN/A$439.31M$205.42M12.78N/ANews CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionCELCCelcuity1.002 of 5 stars$46.66+1.7%$39.20-16.0%+211.6%$1.79BN/A-15.4040Earnings ReportAnalyst ForecastShort Interest ↑ARDTArdent Health3.2889 of 5 stars$12.04+1.3%$19.56+62.5%-25.4%$1.70B$5.97B6.6524,900LFSTLifeStance Health Group3.2617 of 5 stars$4.57+4.6%$8.50+86.0%-4.2%$1.70B$1.25B-91.4010,218Positive NewsPACSPACS Group2.5207 of 5 stars$11.35+1.9%$34.29+202.0%-70.5%$1.70B$3.11B0.0032,433News CoverageNHCNational HealthCareN/A$103.43+3.0%N/A-15.3%$1.60B$1.37B12.9612,400Positive NewsVRDNViridian Therapeutics1.5766 of 5 stars$16.89+2.9%$37.00+119.1%+16.9%$1.34B$300K-4.4150AVAHAveanna Healthcare2.2404 of 5 stars$6.83+11.2%$6.10-10.7%+41.6%$1.28B$2.02B85.3833,500News CoverageAnalyst UpgradeGap UpAHCOAdaptHealth3.8931 of 5 stars$9.33+1.5%$13.40+43.6%-10.3%$1.24B$3.26B17.2810,500Positive NewsTDOCTeladoc Health3.2668 of 5 stars$6.79-2.5%$9.76+43.9%+5.2%$1.23B$2.57B-5.705,500Positive NewsGRALGRAIL1.0596 of 5 stars$32.69-0.4%$31.50-3.6%+95.8%$1.18B$125.60M-0.541,360Earnings Report Related Companies and Tools Related Companies CELC Competitors ARDT Competitors LFST Competitors PACS Competitors NHC Competitors VRDN Competitors AVAH Competitors AHCO Competitors TDOC Competitors GRAL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBC) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SBC Medical Group Holdings Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share SBC Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access